Related Experiment Video
Updated: Mar 22, 2026
Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model
Published on: April 2, 2021
Retinopathy of prematurity: An update on screening and management
Insights
Retinopathy of prematurity (ROP) screening and management guidelines are updated. New information covers risk factors, screening schedules, pain control, digital imaging, and anti-VEGF therapy for preterm infants.
Area of Science:
- Ophthalmology
- Neonatology
- Pediatrics
Background:
- Retinopathy of prematurity (ROP) is a significant cause of vision impairment in premature infants.
- Early detection and treatment are crucial to prevent severe visual outcomes.
Purpose of the Study:
- To review current evidence and provide updated recommendations for ROP screening and management.
- To highlight advancements in diagnostic and therapeutic modalities for ROP.
Main Methods:
- Review of recent literature on ROP screening and treatment.
- Analysis of risk factors influencing screening protocols.
- Evaluation of emerging technologies like digital retinal photography.
- Assessment of novel therapeutic agents such as anti-VEGF therapy.
Main Results:
- Risk factor assessment refines screening eligibility and timing.
- Optimized screening schedules improve early detection rates.
- Digital retinal photography offers a potential alternative for remote screening.
- Anti-VEGF therapy shows promise in managing aggressive ROP.
Conclusions:
- Updated guidelines incorporate risk stratification for ROP screening.
- Pain management during examinations is emphasized.
- Technological advancements and new therapies are transforming ROP care.
Abstract:
Retinopathy of prematurity is a proliferative disorder of the developing retinal blood vessels in preterm infants. The present practice point reviews new information regarding screening and management for retinopathy of prematurity, including the role of risk factors in screening, optimal scheduling for screening examinations, pain management, digital retinal photography and antivascular endothelial growth factor therapy.
